Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack

ClinicalTrials.gov ID: NCT00112281

Public ClinicalTrials.gov record NCT00112281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 9:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III International, Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Nitric Oxide Synthase Inhibition With Tilarginine Acetate Injection in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction, or the TRIUMPH Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Tilarginine Acetate Injection is a new type of drug that temporarily stops the body from making a bodily substance called nitric oxide. The body may produce excess nitric oxide following severe heart damage leading to shock. During a heart attack, and especially after a blocked artery causing the heart attack is reopened, a large amount of nitric oxide is released into the heart muscle and into the blood. Normally small amounts of nitric oxide are good for the heart and blood vessels. However, when released in large amounts, such as during a heart attack, it may be harmful, by adding to the damage of the heart attack and lowering the heart's ability to pump blood to the body. It may cause blood pressure to be lowered and reduce the amount of blood flow to the body's vital organs. This may interfere with the body's organs being able to do their work. If Tilarginine Acetate Injection can stop extra nitric oxide from being made, the performance of the heart and blood flow to the organs may get better, which may result in the improvement of symptoms. The purpose of this study (TRIUMPH) is to investigate the safety and effectiveness of Tilarginine Acetate Injection compared to placebo (an inactive fluid that has no effect on the body but looks exactly like the medication being studied). The study will help determine whether Tilarginine Acetate Injection, by temporarily lowering the amount of nitric oxide released into the vital organs can improve blood pressure and the blood flow to the body's organs.

Study identification

NCT ID
NCT00112281
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Arginox Pharmaceuticals
Industry
Enrollment
658 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2005 (Type not available)
Primary completion
Not listed
Completion
Jan 2007 (Type not available)
Last update posted
Aug 4, 2006

2005 – 2007

United States locations

U.S. sites
83
U.S. states
33
U.S. cities
71
Facility City State ZIP Site status
The Heart Group, PC Mobile Alabama 36608 —
Sparks Regional Medical Center Fort Smith Arizona 72901 —
Banner Baywood Heart Hospital Mesa Arizona 85206 —
Mayo Clinic Hospital Phoenix Arizona 85043 —
Central Arkansas Cardiovascular Research Group (CACRG) Little Rock Arkansas 72205 —
Los Angeles Cardiology Associates Los Angeles California 90017 —
University of Southern California, LAC + USC Medical Center Los Angeles California 90033 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
Stanford University School of Medicine Palo Alto California 94305-5406 —
Desert Cardiology Rancho Mirage California 92270 —
Mercy General Hospital Sacramento California 95819 —
South Denver Cardiology Associates, PC Littleton Colorado 80120 —
Christiana Care Health Services Newark Delaware 19718 —
Washington Hospital Center Washington D.C. District of Columbia 20010-2975 —
Florida Cardiovascular Research Center Atlantis Florida 33462 —
Watson Clinic, LLP Lakeland Florida 33805 —
Health First Clinical Research Institute Melbourne Florida 32901 —
University of Miami School of Medicine Miami Florida 33136 —
Mt. Sinai Medical Center Miami Florida 33140 —
Mediquest Research Group Ocala Florida 34471 —
Orlando Regional Medical Center Orlando Florida 32806 —
Cardiovascular Center of Sarasota Sarasota Florida 34239 —
Emory Crawford Long Hospital Atlanta Georgia 30308 —
John H. Stroger Jr. Hospital of Cook County Chicago Illinois 60612 —
Heart Care Midwest Peoria Illinois 61603 —
Trinity Medical Center Rock Island Illinois 61201 —
Parkview Research Center Fort Wayne Indiana 46805 —
Iowa Health, Des Moines Des Moines Iowa 50309 —
Iowa Heart Centre Des Moines Iowa 50314 —
University of Iowa Hospital Iowa City Iowa 52242 —
University of Kansas Hospital Kansas City Kansas 66160 —
University of Kentucky Lexington Kentucky 40536-0200 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Northeast Cardiology Associates Bangor Maine 04401 —
Maine Medical Center Portland Maine 04102 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Boston Medical Center Boston Massachusetts 02118 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Interventional Cardiovascular Research - Lahey Clinic Burlington Massachusetts 01805 —
University of Massachusetts Medical School Worcester Massachusetts 01655 —
Fallon Cardiology - St. Vincent Hospital Worchester Massachusetts 01608 —
University of Michigan Health Systems Ann Arbor Michigan 48109-0311 —
Henry Ford Hospital Detroit Michigan 48202 —
Spectrum Health Hospitals Grand Rapids Michigan 49525 —
Nisus Research at Northern Michigan Hospital Petoskey Michigan 49770 —
William Beaumont Hospital Royal Oak Michigan 48073-6769 —
St. Mary's Duluth Clinic Health System Duluth Minnesota 55805 —
Mayo Clinic Minnesota Rochester Minnesota 55905 —
Saint Louis University St Louis Missouri 63110 —
Washington University St Louis Missouri 63110 —
BryanLGH Heart Institute Lincoln Nebraska 68516 —
University of Nebraska Medical Center Omaha Nebraska 68198-2265 —
Cooper Health System Camden New Jersey 08103 —
Newark Beth Israel Medical Center Newark New Jersey 07112 —
Lenox Hill Heart and Vascular Institute of New York New York New York 10021 —
Mount Sinai Medical Center New York New York 10029 —
Rochester Cardio-Pulmonary Group, P.C. Rochester New York 14621 —
University of Rochester Medical Center Rochester New York 14642 —
Cardiology Associates of Schenectady Schenectady New York 12309 —
Mission Hospitals Asheville North Carolina 28801 —
UNC Chapel Hill Chapel Hill North Carolina 27599-7075 —
Sanger Clinic Charlotte North Carolina 28203 —
Duke University Medical Center Durham North Carolina 27710 —
LeBauer Cardiovascular Research Greensboro North Carolina 27401 —
Forsyth Medical Center Winston-Salem North Carolina 27103 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
MidWest Cardiology Research Foundation Columbus Ohio 43214 —
The Oregon Clinic Portland Oregon 97213-2281 —
Providence Heart & Vascular Institute Portland Oregon 97225 —
The Heart Care Group Allentown Pennsylvania 18106 —
Penn State Hershey Medical Center Hershey Pennsylvania 17033-0850 —
Lancaster General Hospital Lancaster Pennsylvania 17603 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
Guthrie Clinic Sayre Pennsylvania 18830 —
The Miriam Hospital Providence Rhode Island 02906 —
South Carolina Heart Center Columbia South Carolina 29204 —
Johnson City Medical Center Johnson City Tennessee 37601 —
St. Thomas Cardiology Consultants Nashville Tennessee 37205 —
Ben Taub General Hospital, Baylor College of Medicine Houston Texas 77030 —
The Methodist Hospital Houston Texas 77030 —
University of Texas Medical School Houston Texas 77030 —
LDS Hospital Salt Lake City Utah 84143 —
Fletcher Allen Healthcare Burlington Vermont 05401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00112281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 4, 2006 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00112281 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →